Search

Search Constraints

You searched for: Author/Creator Levin, Einav G.

Search Results

2. Efficacy and safety of BNT162b2 vaccination in patients with solid cancer receiving anticancer therapy – a single centre prospective study. (November 2021)

3. Immunogenicity and Adverse Effects of the 2‐Dose BNT162b2 Messenger RNA Vaccine Among Liver Transplantation Recipients. Issue 2 (8th December 2021)

4. Letter of response to comment on: Efficacy and safety of BNT162b2 vaccination in solid cancer patients receiving anti-cancer therapy - A single centre prospective study. (January 2022)

6. Seropositivity and neutralising antibodies at six months after BNT162b2 vaccination in patients with solid tumours. (June 2022)